Company Profile

ProPhase Labs Stock Price, News & Analysis

Ticker:
PRPH
Exchange:
NASDAQ
Sector:
Biotechnology
Location:
Headquartered in the United States and listed on NASDAQ, ProPhase Labs is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles.

Stock performance

0.11 USD (+45.50%)

Close

Last updated: June 23, 2026 at 00:00

Market cap

Why the stock is moving

PRPH is trading with a steady catalyst profile while investors wait for the next headline that changes the story.

Company overview

Business overview

ProPhase Labs is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NASDAQ, ProPhase Labs is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles.

Business Model Characteristics

ProPhase Labs is a commercial-tools story where install base, recurring demand, and product adoption drive the narrative more than one-off clinical events.

Position Within the Biotechnology Landscape

Compared with therapeutic biotech names, ProPhase Labs sits on a different part of the landscape where utilization, customer demand, and product refresh tend to matter more than binary FDA events.

Future catalysts

Recent news

The five most recent feed items are shown below in reverse chronological order.

  1. 01
  2. 02
  3. 03
  4. 04
  5. 05

    ProPhase Labs Uplists from Pink Sheets to OTC Market

    Source: ProPhase Labs

Similar stocks

Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

Frequently Asked Questions

What is the current stock price of ProPhase Labs (PRPH)?

ProPhase Labs (PRPH) most recently closed at 0.11 USD, a +45.50% move versus the previous session.

What does ProPhase Labs do?

ProPhase Labs is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.

On which exchange is PRPH stock listed?

ProPhase Labs (PRPH) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, ProPhase Labs is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles., Biotechnology.

What is ProPhase?

ProPhase Labs is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.

Which conditions is ProPhase Labs targeting with ProPhase?

ProPhase Labs is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.

What is Labs?

ProPhase Labs is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.